129 related articles for article (PubMed ID: 3244661)
1. Dynamics of bromodeoxyuridine incorporation into DNA of squamous carcinoma cells during mid and late logarithmic growth.
Shapira A; Wagner JG; Wollner IS; Maybaum J; Stetson PL; Ensminger WD; Carey TE
Pharm Res; 1988 Aug; 5(8):518-22. PubMed ID: 3244661
[TBL] [Abstract][Full Text] [Related]
2. Decrease in TTP pools mediated by 5-bromo-2'-deoxyuridine exposure in a human glioblastoma cell line.
Shewach DS; Ellero J; Mancini WR; Ensminger WD
Biochem Pharmacol; 1992 Apr; 43(7):1579-85. PubMed ID: 1567479
[TBL] [Abstract][Full Text] [Related]
3. Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study.
Eisbruch A; Robertson JM; Johnston CM; Tworek J; Reynolds KR; Roberts JA; Lawrence TS
J Clin Oncol; 1999 Jan; 17(1):31-40. PubMed ID: 10458215
[TBL] [Abstract][Full Text] [Related]
4. [Bromodeoxyuridine-induced weakening of DNA--protein interaction in chromatin according to nucleoprotein--celite chromatography].
Zaboĭkin MM; Kolobkov SL; S'iakste NI; Likhtenshteín AV; Shapot VS
Biull Eksp Biol Med; 1980 Apr; 89(4):420-2. PubMed ID: 7388157
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of myoblast fusion after one round of DNA synthesis in 5-bromodeoxyuridine.
Bischoff R; Holtzer H
J Cell Biol; 1970 Jan; 44(1):134-50. PubMed ID: 4242927
[TBL] [Abstract][Full Text] [Related]
6. Requirement of bromodeoxyuridine for the maintenance of "transformed" characteristics in bromodeoxyuridine dependent cells.
Horn D; Davidson RL
J Cell Physiol; 1975 Apr; 85(2 Pt 1):251-60. PubMed ID: 164475
[TBL] [Abstract][Full Text] [Related]
7. Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
Danova M; Riccardi A; Gaetani P; Wilson GD; Mazzini G; Brugnatelli S; Buttini R; Butti G; Ucci G; Paoletti P
Eur J Cancer Clin Oncol; 1988 May; 24(5):873-80. PubMed ID: 3169092
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rRNA synthesis following incorporation of 5-bromodeoxyuridine into DNA of Tetrahymena pyriformis.
Lykkesfeldt AE; Andersen HA
J Cell Sci; 1975 May; 17(3):495-502. PubMed ID: 806606
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 5-bromo-2-deoxyuridine and [3H]thymidine for studies of hepatocellular proliferation in rodents.
Lanier TL; Berger EK; Eacho PI
Carcinogenesis; 1989 Jul; 10(7):1341-3. PubMed ID: 2736724
[TBL] [Abstract][Full Text] [Related]
10. Preferential inhibition of rDNA transcription by 5-bromodeoxyuridine.
Lykkesfeldt AE; Andersen HA
J Cell Sci; 1977 Jun; 25():95-102. PubMed ID: 408368
[TBL] [Abstract][Full Text] [Related]
11. Dependency of sister chromatid exchange in T- and B-cells on the incorporation of deoxyribonucleosides into chromosomal DNA.
Shiraishi Y; Weinfeld H; Minowada J; Sandberg AA
J Natl Cancer Inst; 1976 Dec; 57(6):1217-24. PubMed ID: 1087352
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to bromodeoxyuridine in a thymidine-requiring strain of Bacillus subtilis.
Coote JG; Binnie C
J Gen Microbiol; 1986 Feb; 132(2):481-92. PubMed ID: 2423635
[TBL] [Abstract][Full Text] [Related]
13. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.
Braakhuis BJ; Jansen G; Noordhuis P; Kegel A; Peters GJ
Biochem Pharmacol; 1993 Dec; 46(12):2155-61. PubMed ID: 7506025
[TBL] [Abstract][Full Text] [Related]
14. Cell kinetics evaluation of colorectal tumors after in vivo administration of bromodeoxyuridine.
Roncucci L; Pedroni M; Scalmati A; Bormioli ML; Sassatelli R; Fante R; Losi L; Di Gregorio C; Petocchi B; Ponz de Leon M
Int J Cancer; 1992 Dec; 52(6):856-61. PubMed ID: 1459724
[TBL] [Abstract][Full Text] [Related]
15. The effects of controlled substitution of 5-bromodeoxyuridine (BUdR) for thymidine in hepatoma cell DNA.
O'Brien JC; Stellwagen RH
Exp Cell Res; 1977 Jun; 107(1):119-25. PubMed ID: 16759
[No Abstract] [Full Text] [Related]
16. Flow cytometric cell cycle analysis using the quenching of 33258 Hoechst fluorescence by bromodeoxyuridine incorporation.
Böhmer RM
Cell Tissue Kinet; 1979 Jan; 12(1):101-10. PubMed ID: 369699
[TBL] [Abstract][Full Text] [Related]
17. [In-vivo marking of human tumors using BUDR for flow-cytometry determination of kinetic cell parameters].
Kärcher H; McNally NJ; Wilson G; Kärcher KH; Pfragner R
Strahlenther Onkol; 1987 Mar; 163(3):195-200. PubMed ID: 3563881
[TBL] [Abstract][Full Text] [Related]
18. 5-bromodeoxyuridine (BUdR) quenching of acridine orange fluorescence distinguishes cycling and non-cycling normal and malignant bone marrow cells in vitro.
Maddox AM; Johnson DA; Keating MJ
Leuk Res; 1989; 13(9):781-90. PubMed ID: 2796384
[TBL] [Abstract][Full Text] [Related]
19. The effects of 5-bromodeoxyuridine on yolk sac erythropoiesis in the chick embryo.
Miura Y; Wilt FH
J Cell Biol; 1971 Mar; 48(3):523-32. PubMed ID: 5101841
[TBL] [Abstract][Full Text] [Related]
20. Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.
Teodori L; Trinca ML; Goehde W; Hemmer J; Salvati F; Storniello G; Mauro F
Int J Cancer; 1990 Jun; 45(6):995-1001. PubMed ID: 2161804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
